Mylan Would Launch Nebivolol For Hypertension If Heart Failure Indication Is Delayed
Timeline could hinge on FDA’s acceptance of heart failure data from the SENIORS trial; nebivolol is currently “approvable” for hypertension.
Timeline could hinge on FDA’s acceptance of heart failure data from the SENIORS trial; nebivolol is currently “approvable” for hypertension.